List of articles with "Alzheimer's"

Leqembi Data Unveiled

Leqembi Data Unveiled

Eisai Leqembi Alzheimer's
Eisai's LEQEMBI Data Reveal Breakthroughs

Eisai's LEQEMBI Data Reveal Breakthroughs

Japan Tokyo Eisai Leqembi Alzheimer's
Eisai Presents E2814 Data

Eisai Presents E2814 Data

Japan Tokyo Eisai Alzheimer's Etalanetug
Tazbentetol Approved

Tazbentetol Approved

USA Los Angeles Alzheimer's Spinogenix Tazbentetol
Lighthouse Pharmaceuticals at CTAD 2025

Lighthouse Pharmaceuticals at CTAD 2025

United States San Diego Alzheimer's Lighthouse LHP588
LEQEMBI IQLIK FDA Submission

LEQEMBI IQLIK FDA Submission

Japan Tokyo Eisai Leqembi Alzheimer's
Semaglutide Trials

Semaglutide Trials

United States New York Alzheimer's Semaglutide Novo Nordisk
Akeso's Alzheimer's Breakthrough

Akeso's Alzheimer's Breakthrough

China Hong Kong Alzheimer's Akeso AK152
Pine Glo Memory Care

Pine Glo Memory Care

USA Alzheimer's Zebulon Pine Glo Reminiscents Project
Leqembi Approved in Canada

Leqembi Approved in Canada

Canada Stockholm Lecanemab Leqembi Alzheimer's
Dr. Fortea's Alzheimer's Research

Dr. Fortea's Alzheimer's Research

USA Washington Alzheimer's ApoE4 Dr. Fortea
Tau Aggregation Breakthrough

Tau Aggregation Breakthrough

Japan Tokyo Alzheimer's Tau Protein Precursor Cluster
LEQEMBI IQLIK™ Wins TIME Honor

LEQEMBI IQLIK™ Wins TIME Honor

Japan Tokyo Leqembi Alzheimer's IQLIK
NULISAqpcr™ BD-pTau217

NULISAqpcr™ BD-pTau217

USA Alzheimer's Fremont, California Alamar Biosciences NULISAqpcr
Neuraceq® Production Boost

Neuraceq® Production Boost

United States Alzheimer's Neuraceq Life Molecular Imaging Decatur, IL
Improving Alzheimer's Trials

Improving Alzheimer's Trials

Canada Toronto Alzheimer's Parkinson's Biomarkers
Leqembi Iqlik Launch

Leqembi Iqlik Launch

USA Stockholm Eisai Leqembi Alzheimer's
Leqembi® Approved

Leqembi® Approved

China Beijing Leqembi BioArctic Alzheimer's
Kisunla Approved

Kisunla Approved

None Alzheimer's Kisunla Donanemab
Gene Mutation and Alzheimer's

Gene Mutation and Alzheimer's

United States Alzheimer's Endeavor Health Evanston PICALM
Phase 2 Trial for ADP

Phase 2 Trial for ADP

USA San Francisco Alzheimer's ML-007C-MA MapLight
Etalanetug Fast Track

Etalanetug Fast Track

Japan Tokyo Eisai Alzheimer's Etalanetug
Alzheimer's Awareness

Alzheimer's Awareness

USA Chicago Alzheimer's Hispanic Families Telenovela
NeuroSense Drug Advances

NeuroSense Drug Advances

USA Cambridge Alzheimer's NeuroSense PrimeC
EEG Test for Alzheimer's

EEG Test for Alzheimer's

United Kingdom Alzheimer's Belfast Cumulus Neuroscience Fastball EEG
Leqembi Approval

Leqembi Approval

United States New York FDA Approval Leqembi Alzheimer's
Xanamem Trial Update

Xanamem Trial Update

Australia Sydney Alzheimer's Xanamem Actinogen
Cerecin and NIHR Team Up

Cerecin and NIHR Team Up

USA Denver Alzheimer's Cerecin NIHR HealthTech
Leqembi Launches in EU

Leqembi Launches in EU

Sweden Stockholm Leqembi BioArctic Alzheimer's
Selonterra's New Patent

Selonterra's New Patent

United States biotech San Mateo Alzheimer's Selonterra
Labcorp Alzheimer's Test

Labcorp Alzheimer's Test

USA Labcorp Alzheimer's Blood Test Burlington, North Carolina
LEQEMBI® Study Insights

LEQEMBI® Study Insights

United States Cambridge Lecanemab Leqembi Alzheimer's
LEQEMBI® Treatment Update

LEQEMBI® Treatment Update

Japan Tokyo Eisai Leqembi Alzheimer's
Alzheimer's Diagnostics

Alzheimer's Diagnostics

USA Rockville Alzheimer's TrilliumBiO T-NeuroDx
Creyos at AAIC 2025

Creyos at AAIC 2025

Canada Toronto Alzheimer's cognitive health Creyos
Advances in Alzheimer's Diagnostics

Advances in Alzheimer's Diagnostics

United States Alzheimer's Carlsbad ALZpath pTau217
Cumulus at AAIC 2025

Cumulus at AAIC 2025

Canada Toronto Alzheimer's Cumulus Neuroscience CNS-101
Donanemab Approved?

Donanemab Approved?

None Alzheimer's Eli Lilly Donanemab
Lecanemab Efficacy Data

Lecanemab Efficacy Data

Sweden Stockholm Lecanemab Eisai Alzheimer's
Kisunla FDA Approval

Kisunla FDA Approval

USA Indianapolis Alzheimer's Lilly Kisunla
Neuraceq® Approval

Neuraceq® Approval

USA FDA Approval Boston Alzheimer's Neuraceq®
Lannfelt Awarded in 2025

Lannfelt Awarded in 2025

Sweden Stockholm Lecanemab BioArctic Alzheimer's
CaringKind Gala 2025

CaringKind Gala 2025

United States New York City Alzheimer's Dementia CaringKind
Hearing Loss and Alzheimer's

Hearing Loss and Alzheimer's

USA HearingLoss Alzheimer's Worcester DrDarrow
Neurogen and Aranscia

Neurogen and Aranscia

USA Chicago Alzheimer's Aranscia Neurogen
Alzheimer's Vaccine Funding

Alzheimer's Vaccine Funding

United States Irvine Alzheimer's Duvax Nuravax
ApoE4 Alzheimer's Alliance

ApoE4 Alzheimer's Alliance

USA Washington FDA Alzheimer's ApoE4
ADDF Advances AI Tool

ADDF Advances AI Tool

USA New York Alzheimer's ADDF MoCA Solo
LillyDirect Alzheimer's Care

LillyDirect Alzheimer's Care

United States Indianapolis Alzheimer's Eli Lilly LillyDirect
Judy's Inspirational Journey

Judy's Inspirational Journey

USA California Alzheimer's Judy Benjamin Bredesen Protocol

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.